Loading clinical trials...
Loading clinical trials...
The Risk of Cardiovascular Events Among HIV Patients Initiating Efavirenz-containing Versus Efavirenz-free Antiretroviral Regimens
Conditions
Interventions
Efavirenz
Start Date
December 1, 2014
Primary Completion Date
January 1, 2015
Completion Date
January 1, 2015
Last Updated
April 27, 2015
NCT06741631
NCT06741618
NCT07072481
NCT03135886
NCT06367348
NCT04466488
Lead Sponsor
Bristol-Myers Squibb
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions